$SCND
SCIENTIFIC INDUSTRIES INC Stock $scnd

$scnd Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000165495424006395 Filed on May 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$2.647M	$2.484M
YoY Change	-11.24%	-11.47%
Cost Of Revenue	$1.355M	$1.443M
YoY Change	-17.0%	-1.68%
Gross Profit	$1.292M	$1.041M
YoY Change	-4.27%	-22.21%
Gross Profit Margin	48.82%	41.91%
Selling, General & Admin	$1.963M	$2.420M
YoY Change	-32.13%	-19.72%
% of Gross Profit	151.86%	232.48%
Research & Development	$666.0K	$710.7K
YoY Change	-2.7%	-10.21%
% of Gross Profit	51.53%	68.28%
Depreciation & Amortization	$189.2K	$188.1K
YoY Change	-0.73%	0.11%
% of Gross Profit	14.64%	18.07%
Operating Expenses	$2.629M	$3.130M
YoY Change	-26.5%	-17.74%
Operating Profit	-$1.336M	-$2.090M
YoY Change	-39.98%	-15.32%
Interest Expense	$54.60K	$42.20K
YoY Change	47.57%	348.94%
% of Operating Profit
Other Income/Expense, Net	$52.60K	$37.90K
YoY Change	27.98%	-60.4%
Pretax Income	-$1.284M	-$2.052M
YoY Change	-41.26%	-13.5%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.284M	-$2.052M
YoY Change	-44.0%	-13.45%
Net Earnings / Revenue	-48.49%	-82.61%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.12	-$0.20
COMMON SHARES
Basic Shares Outstanding	10.50M shares	10.50M shares
Diluted Shares Outstanding	10.50M shares	10.44M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.856M	$4.757M
YoY Change	54.93%	6.69%
Cash & Equivalents	$560.5K	$351.7K
Short-Term Investments	$3.295M	$4.405M
Other Short-Term Assets	$444.6K	$468.8K
YoY Change	-17.25%	-3.64%
Inventory	$5.396M	$4.868M
Prepaid Expenses
Receivables	$1.215M	$1.145M
Other Receivables	$73.60K	$161.4K
Total Short-Term Assets	$10.39M	$11.40M
YoY Change	9.86%	-0.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$999.8K	$1.050M
YoY Change	-14.43%	-9.89%
Goodwill	$115.3K	$115.3K
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments		$716.8K
YoY Change
Other Assets	$59.40K	$59.40K
YoY Change	2.06%	2.06%
Total Long-Term Assets	$3.889M	$4.147M
YoY Change	-18.06%	-15.22%
TOTAL ASSETS
Total Short-Term Assets	$10.39M	$11.40M
Total Long-Term Assets	$3.889M	$4.147M
Total Assets	$14.28M	$15.55M
YoY Change	0.53%	-5.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$712.6K	$767.4K
YoY Change	11.2%	-20.94%
Accrued Expenses	$685.9K	$887.4K
YoY Change	-25.94%	-6.9%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.774M	$2.050M
YoY Change	3.51%	-4.12%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$819.4K	$877.0K
YoY Change	-29.17%	-24.19%
Total Long-Term Liabilities	$819.4K	$877.0K
YoY Change	-29.17%	-24.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.774M	$2.050M
Total Long-Term Liabilities	$819.4K	$877.0K
Total Liabilities	$2.593M	$2.927M
YoY Change	-9.66%	-11.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$30.82M	-$29.54M
YoY Change	33.65%	42.21%
Common Stock	$42.53M	$42.20M
YoY Change	12043.86%	11915.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.68M	$12.62M
YoY Change
Total Liabilities & Shareholders Equity	$14.28M	$15.55M
YoY Change	0.53%	-5.0%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$1.284M	-$2.052M
YoY Change	-44.0%	-13.45%
Depreciation, Depletion And Amortization	$189.2K	$188.1K
YoY Change	-0.73%	0.11%
Cash From Operating Activities	-$871.7K	-$1.565M
YoY Change	-54.48%	-10.29%
INVESTING ACTIVITIES
Capital Expenditures	$24.70K	$47.50K
YoY Change	-59.11%	3.71%
Acquisitions
YoY Change
Other Investing Activities	$1.115M	$528.1K
YoY Change	-27.58%	-43.79%
Cash From Investing Activities	$1.090M	$480.6K
YoY Change	-26.29%	-46.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$645.7K
YoY Change
NET CHANGE
Cash From Operating Activities	-871.7K	-$1.565M
Cash From Investing Activities	1.090M	$480.6K
Cash From Financing Activities	0.000	$645.7K
Net Change In Cash	218.4K	-$444.4K
YoY Change	-150.08%	-47.58%
FREE CASH FLOW
Cash From Operating Activities	-$871.7K	-$1.565M
Capital Expenditures	$24.70K	$47.50K
Free Cash Flow	-$896.4K	-$1.613M
YoY Change	-54.62%	-9.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000087802
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.05 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	SCND
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	33600	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	0-6658
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	SCIENTIFIC INDUSTRIES, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-2217279
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	80 Orville Drive
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Bohemia
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11716
CY2024Q1	dei	City Area Code CityAreaCode	631
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	567-4700
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10503599	shares
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	351700	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	796100	usd
CY2024Q1	scnd	Available For Sales Securities Current AvailableForSalesSecuritiesCurrent	4404800	usd
CY2023Q4	scnd	Available For Sales Securities Current AvailableForSalesSecuritiesCurrent	4928700	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	33600	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1144900	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1157100	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	4868200	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4883900	usd
CY2024Q1	us-gaap	Income Tax Receivable IncomeTaxReceivable	161400	usd
CY2023Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	161400	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	468800	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	413500	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	11399800	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	12340700	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1050100	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1082300	usd
CY2024Q1	us-gaap	Goodwill Goodwill	115300	usd
CY2023Q4	us-gaap	Goodwill Goodwill	115300	usd
CY2024Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1124000	usd
CY2023Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1249900	usd
CY2024Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	607000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	609000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1190900	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1273900	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	59400	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	59400	usd
CY2024Q1	us-gaap	Assets Assets	15546500	usd
CY2023Q4	us-gaap	Assets Assets	16730500	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	767400	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	711700	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	887400	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	777900	usd
CY2024Q1	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	24500	usd
CY2023Q4	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	23600	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	371100	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	324100	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2050400	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1837300	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	877000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1007800	usd
CY2024Q1	us-gaap	Liabilities Liabilities	2927400	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2845100	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10503599	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10145211	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10503599	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10145211	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	525200	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	507300	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	41672300	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	40844600	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-41700	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	18600	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-29536700	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27485100	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	12619100	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13885400	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15546500	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16730500	usd
CY2024Q1	us-gaap	Revenues Revenues	2483500	usd
CY2023Q1	us-gaap	Revenues Revenues	2805400	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	1442700	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1467400	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	1040800	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1338000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1521800	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1569300	usd
CY2024Q1	us-gaap	Selling Expense SellingExpense	897800	usd
CY2023Q1	us-gaap	Selling Expense SellingExpense	1444800	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	710700	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	791500	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	3130300	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	3805600	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2089500	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2467600	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4300	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	86300	usd
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	42200	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	9400	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	37900	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	95700	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2051600	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2371900	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2051600	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2371900	usd
CY2024Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	usd
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	1400	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2051600	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2370500	usd
CY2024Q1	scnd	Other Comprehensive Income Loss Unrealized Holding Gain Loss On Investment Securities Net Of Tax OtherComprehensiveIncomeLossUnrealizedHoldingGainLossOnInvestmentSecuritiesNetOfTax	0	usd
CY2023Q1	scnd	Other Comprehensive Income Loss Unrealized Holding Gain Loss On Investment Securities Net Of Tax OtherComprehensiveIncomeLossUnrealizedHoldingGainLossOnInvestmentSecuritiesNetOfTax	3700	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-60300	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	40200	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-60300	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	43900	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-2111900	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-2326600	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.20
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.34
CY2024Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2024Q1	scnd	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.20
CY2023Q1	scnd	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.34
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13885400	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2051600	usd
CY2024Q1	scnd	Issuance Of Common Stock And Warrants Net Of Issuance Costs Note7 Amount IssuanceOfCommonStockAndWarrantsNetOfIssuanceCostsNote7Amount	221900	usd
CY2024Q1	scnd	Fair Value Modification Of Warrants Recorded As Stock Issuance Costs FairValueModificationOfWarrantsRecordedAsStockIssuanceCosts	423800	usd
CY2024Q1	scnd	Other Comprehensive Income Loss Foreign Currency Transactions And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionsAndTranslationAdjustmentNetOfTax	-60300	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	199900	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	12619100	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14792600	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2370500	usd
CY2023Q1	scnd	Other Comprehensive Income Loss Foreign Currency Transactions And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionsAndTranslationAdjustmentNetOfTax	40200	usd
CY2023Q1	scnd	Unrealized Holding Gain On Investment Securities Net Of Tax UnrealizedHoldingGainOnInvestmentSecuritiesNetOfTax	3700	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	602600	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	13068600	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-2051600	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2370500	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	188100	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	187900	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	199900	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	602600	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-1400	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-69200	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	5600	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	112800	usd
CY2024Q1	scnd	Increase Decrease In Right Of Use Assets IncreaseDecreaseInRightOfUseAssets	82500	usd
CY2023Q1	scnd	Increase Decrease In Right Of Use Assets IncreaseDecreaseInRightOfUseAssets	75500	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-9600	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-143200	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	19500	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	338600	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	55800	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	27100	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	110200	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	151900	usd
CY2024Q1	us-gaap	Increase Decrease In Commodity Contract Assets And Liabilities IncreaseDecreaseInCommodityContractAssetsAndLiabilities	-900	usd
CY2023Q1	us-gaap	Increase Decrease In Commodity Contract Assets And Liabilities IncreaseDecreaseInCommodityContractAssetsAndLiabilities	119500	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-83000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-77500	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1565100	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1744700	usd
CY2024Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	247300	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	791800	usd
CY2024Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	775400	usd
CY2023Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	1731300	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	47500	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	45800	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	480600	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	893700	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	716800	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2024Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	71100	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	645700	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-5600	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3300	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-444400	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-847700	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	796100	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1927100	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	351700	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1079400	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	716776	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3530800	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3436300	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	108000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	23200	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1836400	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2033400	usd
CY2024Q1	scnd	Inventory Net1 InventoryNet1	5475200	usd
CY2023Q4	scnd	Inventory Net1 InventoryNet1	5492900	usd
CY2024Q1	scnd	Inventories Current Assets InventoriesCurrentAssets	4868200	usd
CY2023Q4	scnd	Inventories Current Assets InventoriesCurrentAssets	4883900	usd
CY2024Q1	scnd	Inventories Noncurrent Assets InventoriesNoncurrentAssets	607000	usd
CY2023Q4	scnd	Inventories Noncurrent Assets InventoriesNoncurrentAssets	609000	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	127000	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	130000	usd
CY2024Q1	scnd	Weighted Average Common Shares Outstanding WeightedAverageCommonSharesOutstanding	10436647	shares
CY2023Q1	scnd	Weighted Average Common Shares Outstanding WeightedAverageCommonSharesOutstanding	7003599	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10436647	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7003599	shares
CY2024Q1	scnd	Income Loss From Continuing Operations Per Basic And Diluted Share Continuing Operations IncomeLossFromContinuingOperationsPerBasicAndDilutedShareContinuingOperations	-0.20
CY2023Q1	scnd	Income Loss From Continuing Operations Per Basic And Diluted Share Continuing Operations IncomeLossFromContinuingOperationsPerBasicAndDilutedShareContinuingOperations	-0.34
CY2024Q1	scnd	Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share Discontinued Operation IncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShareDiscontinuedOperation	0
CY2023Q1	scnd	Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share Discontinued Operation IncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShareDiscontinuedOperation	0
CY2024Q1	scnd	Consolidated Operations Earnings Per Share Basic And Diluted ConsolidatedOperationsEarningsPerShareBasicAndDiluted	-0.20
CY2023Q1	scnd	Consolidated Operations Earnings Per Share Basic And Diluted ConsolidatedOperationsEarningsPerShareBasicAndDiluted	-0.34
CY2024Q1	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0.10	pure

Files In Submission

Name	View Source	Status
scnd-20240331_cal.xml	Edgar Link	unprocessable
0001654954-24-006395-index-headers.html	Edgar Link	pending
0001654954-24-006395-index.html	Edgar Link	pending
0001654954-24-006395.txt	Edgar Link	pending
0001654954-24-006395-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
scnd-20240331.xsd	Edgar Link	pending
scnd_10q.htm	Edgar Link	pending
scnd_ex311.htm	Edgar Link	pending
scnd_ex312.htm	Edgar Link	pending
scnd_ex321.htm	Edgar Link	pending
scnd_ex322.htm	Edgar Link	pending
Show.js	Edgar Link	pending
scnd-20240331_def.xml	Edgar Link	unprocessable
scnd-20240331_lab.xml	Edgar Link	unprocessable
scnd-20240331_pre.xml	Edgar Link	unprocessable
scnd_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCND
SCIENTIFIC INDUSTRIES INC Stock $scnd

2024 Q2 Form 10-Q Financial Statement

#000165495424006395 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCND SCIENTIFIC INDUSTRIES INC Stock $scnd

2024 Q2 Form 10-Q Financial Statement

#000165495424006395 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCND
SCIENTIFIC INDUSTRIES INC Stock $scnd